Evidence map›Paper›PMID 42191024›Full record

ReviewVirus research2026

Two target cells for HPV infection at the cervix?

Olaf Reich, Sigrid Regauer

Erratum issuedAbstract readReview
In one paragraph

Review in Virus research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Olaf ReichDepartment of Obstetrics & Gynecology, Medical University of Graz, Graz, Austria. Electronic address: olaf.reich@medunigraz.at.
Sigrid RegauerInstitute for Pathology, Medical University of Graz, Graz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the 1980s human papilloma virus (HPV) was identified as the cause of nearly all squamous cell cervical cancers (SCC), and the primary site of HPV infection at the cervix was long believed to be the basal cells of mature squamous epithelium. Considerable evidence now points to subcolumnar reserve cells (RC) nested in the endocervical epithelium as an alternative HPV target. Proof of the RC concept are i) HPV E6/E7 mRNA transcripts in histologically bland appearing p16 overexpressing thin HSIL, ii) similar genomic alterations in RC thin HSIL and invasive cervical SCC, and iii) HPV E6/E7 mRNA in endocervical RC adjacent to the preneoplastic regions. Even to date both the IARC and IPVS focus almost exclusively on HPV-associated cervical carcinogenesis originating in mature squamous cervical epithelium. The concept of dual carcinogenesis with distinct target cells for HPV at the cervix better explains most of the observations related to the natural history of cervical SCC. Further experimental substantiation of the RC as target cells for HPV and cell of origin of squamous (pre)cancer and the regulation of E6/7 expression in HPV infected proliferating RC and active metaplasia in the development of HSIL is needed. Furthermore, prospective in vivo studies of p16-positive thin HSIL lesions are necessary to document the risk of progression, but may be difficult to conduct for ethical reasons.

Indexed as

Cervix UteriHuman Papillomavirus VirusesPapillomavirus InfectionsUterine Cervical NeoplasmsAnimalsFemaleHumansOncogene Proteins, ViralOncogene Proteins, ViralBasal cellsCervical carcinogenesisCervixHPVHPV research modelReserve cells

Identifiers

PMID42191024
PMCPMC13231011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.